Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Allan Andresson Lima Pereira

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8573-7364; OpenAlex author ID A5080676838. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment. Co-author DOI 10.1200/po-25-00807↗
  2. Development of new therapies for metastatic pancreatic cancer: are they better than FOLFIRINOX? First author DOI 10.1136/esmoopen-2019-000537↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sophie Moravec · 1 shared paper, 2026 · strength 0.20
  2. Dae Won Kim · 1 shared paper, 2026 · strength 0.20
  3. Richard D. Kim · 1 shared paper, 2026 · strength 0.20
  4. Carmelo Blanquicett · 1 shared paper, 2026 · strength 0.20
  5. Nicole Nardella · 1 shared paper, 2026 · strength 0.20
  6. Sarah E. Hoffe · 1 shared paper, 2026 · strength 0.20
  7. Mokenge Peter Malafa · 1 shared paper, 2026 · strength 0.20
  8. Pamela Joy Hodul · 1 shared paper, 2026 · strength 0.20
  9. Jennifer B. Permuth · 1 shared paper, 2026 · strength 0.20
  10. Gustavo dos Santos Fernandes · 1 shared paper, 2019 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.